Dan Wang, MD is the Head of Johnson & Johnson Innovation in Asia Pacific, responsible for managing a portfolio of co-investments and deal execution spanning across all three business sectors of medical devices, pharmaceutical and consumer, and expanding external networks within the innovation ecosystem in the region. On this role, she has led the Asia Pacific Innovation Center in completing multiple research collaboration, co-development, license-in and equity investment collaborations in China, Japan, South Korea, Singapore to enhance the global portfolio and pipeline of Johnson & Johnson. 

Dan has over 20 years’ experience in the life sciences sector. Prior to joining Johnson & Johnson Innovation, Dan worked with Becton Dickinson (BD), e-Capital Corporation， Express Scripts and Johnson & Johnson by leading the local and global Research & Development, Medical Affairs and clinical research teams. Dan has a strong track record in strategic innovation, identifying new product opportunities and external partnerships. 

Dan holds MD and MSc degrees from Peking University as well as an MBA from Goizueta Business School, and an MPH from Rollins School of Public Health at Emory University, Atlanta.